GSK
As of 2026-11-06, GSK plc (GSK) has a market capitalization of $216.72 B, making it the #61 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $216.72 B |
| 2026-11-05 | $217.54 B |
| 2026-11-04 | $220.71 B |
| 2026-11-03 | $210.05 B |
| 2026-11-02 | $212.02 B |
| 2026-11-01 | $213.66 B |
| 2026-10-31 | $213.66 B |
| 2026-10-30 | $214.82 B |
| 2026-10-29 | $210.08 B |
| 2026-10-28 | $209.64 B |
| 2026-10-27 | $220.00 B |
| 2026-10-26 | $220.52 B |
As of 2026-11-06, GSK plc (GSK) has a market capitalization of $216.72 B, making it the #61 most valuable US-listed company.
GSK plc is the #61 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $219.01 B |
| 2026-10-24 | $219.01 B |
| 2026-10-23 | $219.01 B |
| 2026-10-22 | $221.58 B |
| 2026-10-21 | $215.86 B |
| 2026-10-20 | $218.49 B |
| 2026-10-19 | $214.02 B |
| 2026-10-18 | $213.66 B |
| 2026-10-17 | $213.66 B |
| 2026-10-16 | $213.66 B |
| 2026-10-15 | $211.67 B |
| 2026-10-14 | $206.58 B |
| 2026-10-13 | $199.68 B |
| 2026-10-12 | $202.48 B |
| 2026-10-11 | $200.67 B |
| 2026-10-10 | $200.67 B |
| 2026-10-09 | $200.67 B |
| 2026-10-08 | $200.84 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.